Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sue O'Dorisio

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Journal of Pediatric Hematology/Oncology|April 25, 2012
Management of neuroendocrine tumors in children, adolescents, and young adultsDella L Howell, M Sue O'Dorisio
Trends in Endocrinology and Metabolism: TEM|March 1, 1991
Modulation of IgA synthesis by neuroendocrine peptidesG E Hermann, M Sue O'Dorisio
Endocrinology and Metabolism Clinics of North America|February 26, 2011
Neuroendocrine tumors in children and young adults: rare or not so rareMarie-Ellen Sarvida, M Sue O'Dorisio
The Oncologist|May 2, 2008
Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumorsGeetika Khanna, David Bushnell, M Sue O'Dorisio
Cancer Metastasis Reviews|June 27, 2008
Combining anatomic and molecularly targeted imaging in the diagnosis and surveillance of embryonal tumors of the nervous and endocrine systems in childrenM Sue O'Dorisio, Geetika Khanna, David Bushnell
Regulatory Peptides|November 1, 2002
Age-dependent levels of plasma neuropeptides in normal childrenM Sue O'Dorisio, Marsha Hauger, Thomas M O'Dorisio
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic useFarzana D Pashankar, M Sue O'Dorisio, Yusuf Menda
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptideDorit Fabricius, M Sue O'Dorisio, Sue Blackwell, et al.
Surgical Oncology Clinics of North America|March 11, 2020
Evolution of Neuroendocrine Tumor TherapyThomas M O'Dorisio, Alan G Harris, M Sue O'Dorisio
Journal of Molecular Neuroscience : MN|July 30, 2008
The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferationChaneun Nam, Adam J Case, Bruce S Hostager, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Journal of Pediatric Hematology/Oncology|April 25, 2012
Management of neuroendocrine tumors in children, adolescents, and young adultsDella L Howell, M Sue O'Dorisio
Trends in Endocrinology and Metabolism: TEM|March 1, 1991
Modulation of IgA synthesis by neuroendocrine peptidesG E Hermann, M Sue O'Dorisio
Endocrinology and Metabolism Clinics of North America|February 26, 2011
Neuroendocrine tumors in children and young adults: rare or not so rareMarie-Ellen Sarvida, M Sue O'Dorisio
The Oncologist|May 2, 2008
Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumorsGeetika Khanna, David Bushnell, M Sue O'Dorisio
Cancer Metastasis Reviews|June 27, 2008
Combining anatomic and molecularly targeted imaging in the diagnosis and surveillance of embryonal tumors of the nervous and endocrine systems in childrenM Sue O'Dorisio, Geetika Khanna, David Bushnell
Regulatory Peptides|November 1, 2002
Age-dependent levels of plasma neuropeptides in normal childrenM Sue O'Dorisio, Marsha Hauger, Thomas M O'Dorisio
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic useFarzana D Pashankar, M Sue O'Dorisio, Yusuf Menda
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptideDorit Fabricius, M Sue O'Dorisio, Sue Blackwell, et al.
Surgical Oncology Clinics of North America|March 11, 2020
Evolution of Neuroendocrine Tumor TherapyThomas M O'Dorisio, Alan G Harris, M Sue O'Dorisio
Journal of Molecular Neuroscience : MN|July 30, 2008
The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferationChaneun Nam, Adam J Case, Bruce S Hostager, et al.
Pageof 7